Lance Baldo - Net Worth and Insider Trading
Lance Baldo Net Worth
The estimated net worth of Lance Baldo is at least $101,996 dollars as of 2024-11-13. Lance Baldo is the Chief Medical Officer of Adaptive Biotechnologies Corp and owns about 17,171 shares of Adaptive Biotechnologies Corp (ADPT) stock worth over $101,996. Details can be seen in Lance Baldo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lance Baldo has not made any transactions after 2022-03-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lance Baldo
Lance Baldo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lance Baldo owns 1 companies in total, including Adaptive Biotechnologies Corp (ADPT) .
Click here to see the complete history of Lance Baldo’s form 4 insider trades.
Insider Ownership Summary of Lance Baldo
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | 2022-03-08 | Chief Medical Officer |
Lance Baldo Latest Holdings Summary
Lance Baldo currently owns a total of 1 stock. Lance Baldo owns 17,171 shares of Adaptive Biotechnologies Corp (ADPT) as of March 8, 2022, with a value of $101,996.
Latest Holdings of Lance Baldo
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | 2022-03-08 | 17,171 | 5.94 | 101,996 |
Holding Weightings of Lance Baldo
Lance Baldo Form 4 Trading Tracker
According to the SEC Form 4 filings, Lance Baldo has made a total of 14 transactions in Adaptive Biotechnologies Corp (ADPT) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Adaptive Biotechnologies Corp is the sale of 3,350 shares on March 8, 2022, which brought Lance Baldo around $38,291.
Insider Trading History of Lance Baldo
- 1
Lance Baldo Trading Performance
Lance Baldo Ownership Network
Ownership Network List of Lance Baldo
Ownership Network Relation of Lance Baldo
Lance Baldo Owned Company Details
What does Adaptive Biotechnologies Corp do?
Who are the key executives at Adaptive Biotechnologies Corp?
Lance Baldo is the Chief Medical Officer of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include SVP and General Counsel Stacy L Taylor , Chief Commercial Ofc Imm Med Sharon Benzeno , and Chief Financial Officer Tycho Peterson .
Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary
Over the past 18 months, Lance Baldo made no insider transaction in Adaptive Biotechnologies Corp (ADPT). Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 258,417 shares made by Tycho Peterson , a net sale of 40,303 shares made by Stacy L Taylor , and a net sale of 7,986 shares made by Kyle Piskel .
In summary, during the past 3 months, insiders sold 26,922 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 26,922 shares. During the past 18 months, 467,732 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 467,732 shares.
Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptive Biotechnologies Corp Insider Transactions
Lance Baldo Mailing Address
Above is the net worth, insider trading, and ownership report for Lance Baldo. You might contact Lance Baldo via mailing address: C/o Adaptive Biotechnologies Corporation, 1551 Eastlake Ave E Ste 200, Seattle Wa 98102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
